Aesthetic Injectables Market by Product, Gender, Application, End User

Description

List of Tables

[187 Pages Report] The Aesthetic Injectables Market size was estimated at USD 11.08 billion in 2023 and expected to reach USD 11.95 billion in 2024, at a CAGR 7.85% to reach USD 18.81 billion by 2030.

Aesthetic injectables are non-surgical cosmetic treatments that involve injecting substances such as botulinum toxin and dermal fillers into the skin to decrease the appearance of wrinkles, enhance facial contours, and restore lost volume. These procedures are designed to provide a youthful appearance without the need for invasive surgery, offering a quicker, less painful alternative with minimal downtime. The heightened societal emphasis on physical appearance and youthfulness fueled by social media and the influence of celebrities is driving the demand for aesthetic injectables. People are more conscious of their looks and seek treatments that help them maintain a youthful appearance. Advancements in minimally invasive techniques have made these procedures safer and more effective, with fewer side effects and shorter recovery times. Rising disposable incomes, which have enabled more people to afford these treatments are boarding the scope of the market. The potential for side effects and complications, which can include bruising and swelling, with the use of aesthetic injectables hampers the market's growth. These risks can deter potential clients. Continuous innovation in injectable formulations and techniques enhances the efficacy and safety of treatments potentially reducing the side effects, and improving results are expected to create opportunities for market growth.

KEY MARKET STATISTICS
Base Year [2023]	USD 11.08 billion
Estimated Year [2024]	USD 11.95 billion
Forecast Year [2030]	USD 18.81 billion
CAGR (%)	7.85%

Regional Insights

The market for aesthetic injectables in the Americas, particularly North America, is robust and continues to grow due to high disposable incomes, a strong emphasis on physical appearance, and widespread acceptance of cosmetic procedures. The presence of a large number of aesthetic practitioners, continuous advancements in injectable technologies, and significant consumer demand drive the market growth in the Americas. South America is representing continuous growth, spurred by increasing awareness and acceptance of aesthetic treatments. In the Asia-Pacific (APAC) region, the aesthetic injectables market is expanding rapidly, fueled by rising disposable incomes, urbanization, and a growing middle class with a strong interest in beauty and personal care. Countries such as South Korea, Japan, and China are at the forefront, with South Korea particularly known for its advanced cosmetic surgery and non-surgical procedure market. The cultural emphasis on youthful appearances and the influence of social media and celebrity culture are significant drivers. Additionally, the relatively lower procedure cost than in Western countries makes these treatments more accessible. The Europe, Middle East, and Africa (EMEA) region presents a diverse market for aesthetic injectables. Countries such as the United Kingdom, Germany, and France lead with high demand for non-surgical cosmetic procedures, driven by high disposable incomes, strong healthcare systems, and widespread societal acceptance. The Middle East shows significant potential, particularly in affluent countries including the UAE and Saudi Arabia, with a strong demand for luxury and beauty services. In Africa, the market is still emerging, with growth primarily in urban centers where economic conditions are improving and awareness of aesthetic procedures is increasing.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Aesthetic Injectables Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers
- Rising usage of aesthetic injections due to beauty trends and aging population
- Increasing number of spa and beauty salons
- Government and health authority reforms that promote aesthetic treatment options

Market Restraints
- High cost of aesthetic injectables and product recalls

Market Opportunities
- Ongoing innovations in the tools and methods used for administering aesthetic injectables
- Venture capital investments into aesthetic injectable start-ups

Market Challenges
- Health risks associated with aesthetic injectables

Market Segmentation Analysis
- Type: Growing usage of anti-aging injections to reduce the appearance of wrinkles
- End User: High accessibility of aesthetic injectables by dermatology clinics as they provide several cosmetic treatments

Market Disruption Analysis
Porter's Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Aesthetic Injectables Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Aesthetic Injectables Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Cynosure and Lutronic Merge to Form Global Leader in Medical Aesthetic Technology

Cynosure and Hahn & Company, the recent acquirer of Lutronic, have announced their definitive agreement to merge Cynosure and Lutronic. Both companies are prominent energy-based medical aesthetic systems providers, and this merger creates a leading global medical aesthetics technology company. The combined entity features a diverse and innovative product portfolio, operational in over 130 countries. [Published On: 2024-01-20]

Galderma Launches FACE by Galderma, a New AR Tool Helps Visualize Injectable Treatment Results

Galderma has introduced FACE by Galderma, an augmented reality (AR) tool designed for aesthetic professionals and patients to visualize injectable treatment results before the procedure begins. This tool provides a simulated real-time "before and after" visual, helping to address patient concerns about the outcomes of injectable treatment. [Published On: 2023-03-22]

FDA Approves SKINVIVE by JUVEDERM, a new U.S. Hyaluronic Acid Injection for Smoother Cheeks

Allergan Aesthetics, an AbbVie company, has announced the U.S. FDA approval of SKINVIVE by JUVEDERM for enhancing skin smoothness in adults over 21. This product is the first and only hyaluronic acid (HA) intradermal microdroplet injection in the U.S., designed to improve skin quality in the cheeks. The injectable contains a small amount of lidocaine and provides hydration and smoothness, with results lasting up to six months and optimal treatment. [Published On: 2023-03-15]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Aesthetic Injectables Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Aesthetic Injectables Market, highlighting leading vendors and their innovative profiles. These include Adoderm GmbH, Allergan, Inc. by AbbVie Inc., Anika Therapeutics, Inc., Bio Plus Co., Ltd., Bioxis Pharmaceuticals, Bloomage Biotechnology Corp., Ltd., Bohus Biotech AB, Croma-Pharma GmbH, Cutera, Inc., Cynosure, LLC, Dr. Korman Laboratories Ltd., Galderma SA, Hugel America, Inc., Ipsen Pharma, Laboratoires Vivacy, S.A.S., MedyTox Inc., Merz Pharma GmbH & Co.KGaA, Prollenium Medical Technologies Inc., Revance Therapeutics, Inc., SciVision Biotech Inc., Sinclair Pharma Ltd, Suneva Medical, Inc., Teoxane SA, USWM, LLC, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Aesthetic Injectables Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Anti-aging Injections
  - Botulinum Toxin A
  - Poly-L-Lactic Acid (PLLA) Micro Particles

Dermal Fillers
- Collagen Fillers
- Hyaluronic Acid
- Synthetic Fillers

Gender
- Female
- Male

Application
- Acne Scar Treatment
- Face Lift
- Facial Line Correction
- Lip Augmentation
- Lipoatrophy Treatment

End User
- Beauty Clinics
- Dermatology Clinics
- Dermatology Research Institutes
- Medical Spa

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

Product Code: MRR-6702BB6513EA

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising usage of aesthetic injections due to beauty trends and aging population
  - 5.1.1.2. Increasing number of spa and beauty salons
  - 5.1.1.3. Government and health authority reforms that promote aesthetic treatment options
- 5.1.2. Restraints
  - 5.1.2.1. High cost of aesthetic injectables and product recalls
- 5.1.3. Opportunities
  - 5.1.3.1. Ongoing innovations in the tools and methods used for administering aesthetic injectables
  - 5.1.3.2. Venture capital investments into aesthetic injectable start-ups
- 5.1.4. Challenges
  - 5.1.4.1. Health risks associated with aesthetic injectables
5.2. Market Segmentation Analysis
- 5.2.1. Type: Growing usage of anti-aging injections to reduce the appearance of wrinkles
- 5.2.2. End User: High accessibility of aesthetic injectables by dermatology clinics as they provide several cosmetic treatments
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Aesthetic Injectables Market, by Product

6.1. Introduction
6.2. Anti-aging Injections
6.3. Dermal Fillers

7. Aesthetic Injectables Market, by Gender

7.1. Introduction
7.2. Female
7.3. Male

8. Aesthetic Injectables Market, by Application

8.1. Introduction
8.2. Acne Scar Treatment
8.3. Face Lift
8.4. Facial Line Correction
8.5. Lip Augmentation
8.6. Lipoatrophy Treatment

9. Aesthetic Injectables Market, by End User

9.1. Introduction
9.2. Beauty Clinics
9.3. Dermatology Clinics
9.4. Dermatology Research Institutes
9.5. Medical Spa

10. Americas Aesthetic Injectables Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Aesthetic Injectables Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Aesthetic Injectables Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
- 13.3.1. Cynosure and Lutronic Merge to Form Global Leader in Medical Aesthetic Technology
- 13.3.2. Galderma Launches FACE by Galderma, a New AR Tool Helps Visualize Injectable Treatment Results
- 13.3.3. FDA Approves SKINVIVE by JUVEDERM, a new U.S. Hyaluronic Acid Injection for Smoother Cheeks
13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

14.1. Key Company Profiles
14.2. Key Product Portfolio